ReviewClinical Medicine Insights. Oncology2015

Delaying Chemotherapy in the Treatment of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.

Adam M BrufskyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.